A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe ...

Devialet Phantom Ultimate 98 dB and 108 dB fuse next-gen ADH tech with unapologetic French industrial design—because why settle for boring when you can have precision and panache? Headquartered in ...

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe ...

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe ...

The medical-grade glove manufacturing plant that was an expansion of Nephron, one of the largest companies in the Midlands, owes Lexington County nearly $1 million in overdue property taxes despite ...

Nephron Pharmaceuticals, one of the largest employers in Lexington County, has listed its headquarters in West Columbia for sale. The company’s 700,000+ square-foot drug manufacturing facility located ...

Diabetes Insipidus is a rare condition that affects the body’s ability to regulate fluid balance. Unlike the more well-known diabetes mellitus, which involves problems with blood sugar regulation, ...

JONESBORO, Ark. (KAIT) - The Arkansas Department of Health tracks viral respiratory diseases, including influenza, COVID-19, and respiratory syncytial virus (RSV) each week. On Thursday, May 1, the ...

A subsidiary of IHC, ADH has more than 150 subsidiaries across healthcare, renewable energy, petrochemical, real estate, construction, and hospitality. In January 2023, Alpha Dhabi and Mubadala formed ...

A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs for the mass market, little more than a year after the same facility ...

Lexington County-based Nephron Pharmaceuticals is being sued by another drug manufacturer, which claims Nephron products are being marketed as a replacement for its own drug without FDA approval.